Table 1.
Time | Estimated change of number1 | Estimated change of rate2 | p-value | |||||
---|---|---|---|---|---|---|---|---|
Number | 95% CI | % | 95% CI | |||||
Total | Apr-2020 | 689 | − 499 | 1877 | 9 | − 7 | 26 | 0.256 |
Jul-2020 | − 657 | − 1947 | 634 | − 9 | − 27 | 9 | 0.319 | |
Oct-2020 | − 79 | − 1385 | 1227 | − 1 | − 20 | 17 | 0.906 | |
Jan-2021 | 539 | − 770 | 1849 | 8 | − 11 | 26 | 0.420 | |
BCS without ALND | Apr-2020 | 97 | − 188 | 381 | 3 | − 6 | 12 | 0.506 |
Jul-2020 | − 846 | − 1190 | − 502 | − 28 | − 39 | − 16 | < 0.001 | |
Oct-2020 | − 540 | − 861 | − 218 | − 17 | − 27 | − 7 | 0.001 | |
Jan-2021 | 8 | − 384 | 401 | 0 | − 13 | 14 | 0.967 | |
Mastectomy without ALND | Apr-2020 | 134 | − 438 | 707 | 5 | − 18 | 28 | 0.645 |
Jul-2020 | − 136 | − 771 | 500 | − 5 | − 31 | 20 | 0.676 | |
Oct-2020 | 124 | − 568 | 817 | 5 | − 23 | 33 | 0.725 | |
Jan-2021 | 154 | − 591 | 900 | 6 | − 24 | 36 | 0.685 | |
BCS with ALND | Apr-2020 | − 42 | − 289 | 205 | − 8 | − 55 | 39 | 0.741 |
Jul-2020 | − 112 | − 389 | 166 | − 21 | − 75 | 32 | 0.431 | |
Oct-2020 | − 182 | − 487 | 124 | − 35 | − 93 | 24 | 0.244 | |
Jan-2021 | 38 | − 292 | 369 | 7 | − 56 | 71 | 0.820 | |
Mastectomy with ALND | Apr-2020 | 147 | − 138 | 431 | 9 | − 9 | 27 | 0.312 |
Jul-2020 | − 1 | − 339 | 337 | 0 | − 22 | 22 | 0.995 | |
Oct-2020 | − 61 | − 399 | 277 | − 4 | − 26 | 18 | 0.723 | |
Jan-2021 | 9 | − 329 | 347 | 1 | − 21 | 22 | 0.959 |
ALND axillary lymph node dissection, BCS breast-conserving surgery, CI confidence interval.
1Estimated change of number represents the change during the COVID-19 pandemic under the control of underlying trends, autocorrelation, moving average, and seasonality.
2Estimated change of rate was calculated by dividing the estimated change of number by the predicted number in the absence of the pandemic (counterfactual number).